ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,838.56
      -0.73%
      US Tech 100
      20,275.20
      -0.85%
      Dow Jones
      42,231.08
      -0.74%
      Brent Oil
      75.885
      2.75%
      Bitcoin
      96,693.29
      2.44%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. Europe
      5. EU

      6. Celyad Oncology SA (CYAD) Quote

      Celyad Oncology SA

      Celyad Oncology SA (CYAD)

      EU
      0.67
      -0.042
      (-5.90%)
      Closed January 02 11:30AM
      Delayed by 15 minutes

      Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

      Premium

      Key stats and details

      Current Price
      0.67
      Bid
      0.67
      Ask
      0.694
      Volume
      96,402
      0.668 Day's Range 0.716
      0.212 52 Week Range 1.22
      Market Cap
      27.757M
      Previous Close
      0.712
      Open
      0.684
      Last Trade
      541
      @
      0.67
      Last Trade Time
      Financial Volume
      -
      VWAP
      -
      Average Volume (3m)
      97,134
      Shares Outstanding
      41,429,000
      Dividend Yield
      -
      PE Ratio
      -3.29
      Earnings Per Share (EPS)
      -0.2
      Revenue
      102k
      Net Profit
      -8.45M

      About Celyad Oncology SA

      Sector
      Pharmaceutical Preparations
      Industry
      Pharmaceutical Preparations
      Website
      www.celyad.com
      Headquarters
      Mont-saint-guibert, Walloon Brabant, Bel
      Founded
      -
      Celyad Oncology SA is listed in the Pharmaceutical Preparations sector of the Euronext with ticker CYAD. The last closing price for Celyad Oncology was 0.71 €. Over the last year, Celyad Oncology shares have traded in a share price range of 0.212 € to 1.22 €.

      Celyad Oncology currently has 41,429,000 shares outstanding. The market capitalization of Celyad Oncology is 29.50 € million. Celyad Oncology has a price to earnings ratio (PE ratio) of -3.29.

      Ask ADVFN Intelligence (AI)

      CYAD Latest News

      More News

      Celyad Oncology Présentera au Congrès Annuel SITC 2024

      Regulatory News: Celyad Oncology (Euronext: CYAD) (la “Société”), annonce aujourd'hui la présentation de deux posters lors de la 39e réunion annuelle de la Society for Immunotherapy of Cancer...

      October 07 2024
      Business Wire

      Celyad Oncology announces intention to terminate SEC reporting obligations

      MONT-SAINT-GUIBERT, Belgium, Feb. 08, 2024 (GLOBE NEWSWIRE) -- Celyad Oncology SA (Euronext: CYAD) (“Celyad Oncology” or the “Company”) announces that it will voluntarily file a Form 15F with...

      February 08 2024
      GlobeNewswire Inc.

      Celyad Oncology provides fourth quarter 2023 business update and 2024 outlook

      Three main pillars to unlock the potential of proprietary technology platforms and intellectual property: A proprietary non-gene editing technology platform based on multiplexing of short hairpin...

      January 16 2024
      GlobeNewswire Inc.

      Publication of a transparency notification received from Fortress Investment Group LLC (Article 14 §1 of the Law of 2 May 2007)

      MONT-SAINT-GUIBERT, Belgium, Dec. 20, 2023 (GLOBE NEWSWIRE) -- Celyad Oncology SA (Euronext: CYAD) (“Celyad Oncology” or the “Company”) today announces, in accordance with Article 14 of the...

      December 20 2023
      GlobeNewswire Inc.

      Information on the Total Number of Voting Rights and Shares (Article 15 of the Law of 2 May 2007)

      MONT-SAINT-GUIBERT, Belgium, Dec. 15, 2023 (GLOBE NEWSWIRE) -- Celyad Oncology (Euronext: CYAD) (the “Company” or “Celyad Oncology”), today announces that 6,500,000 shares of CFIP CLYD (UK...

      December 15 2023
      GlobeNewswire Inc.

      Celyad announces management change

      MONT-SAINT-GUIBERT, Belgium, Dec. 04, 2023 (GLOBE NEWSWIRE) -- Celyad Oncology (Euronext: CYAD), a cutting-edge biotechnology company dedicated to pioneering the discovery and advancement of...

      December 04 2023
      GlobeNewswire Inc.

      Publication of a transparency notification received from Tolefi SA (Article 14 §1 of the Law of 2 May 2007)

      MONT-SAINT-GUIBERT, Belgium, Dec. 01, 2023 (GLOBE NEWSWIRE) -- regulated information – Celyad Oncology SA (Euronext: CYAD) (“Celyad Oncology” or the “Company”) today announced, in accordance...

      December 01 2023
      GlobeNewswire Inc.

      Publication of a transparency notification received from Fortress Investment Group LLC (Article 14 §1 of the Law of 2 May 2007)

      MONT-SAINT-GUIBERT, Belgium, Nov. 21, 2023 (GLOBE NEWSWIRE) -- Celyad Oncology SA (Euronext: CYAD) (“Celyad Oncology” or the “Company”) today announced, in accordance with Article 14 of the...

      November 21 2023
      GlobeNewswire Inc.

      Information on the Total Number of Voting Rights and Shares (Article 15 of the Law of 2 May 2007)

      MONT-SAINT-GUIBERT, Belgium, Nov. 14, 2023 (GLOBE NEWSWIRE) -- Celyad Oncology (Euronext: CYAD) (the “Company” or “Celyad Oncology”), today announces the below information following the...

      November 14 2023
      GlobeNewswire Inc.
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      1-0.037-5.233380480910.7070.7340.668164300.70800392DE
      4-0.111-14.21254801540.7810.90.661517120.72685281DE
      120.415162.7450980390.2551.220.25971340.73774781DE
      260.411158.6872586870.2591.220.212525730.64362278DE
      520.28272.68041237110.3881.220.212363050.56490112DE
      156-2.855-80.99290780143.5253.660.212388941.11144938DE
      260-9.23-93.23232323239.912.080.212417563.46159386DE

      CYAD - Frequently Asked Questions (FAQ)

      What is the current Celyad Oncology share price?
      The current share price of Celyad Oncology is 0.67 €
      How many Celyad Oncology shares are in issue?
      Celyad Oncology has 41,429,000 shares in issue
      What is the market cap of Celyad Oncology?
      The market capitalisation of Celyad Oncology is EUR 29.5M
      What is the 1 year trading range for Celyad Oncology share price?
      Celyad Oncology has traded in the range of 0.212 € to 1.22 € during the past year
      What is the PE ratio of Celyad Oncology?
      The price to earnings ratio of Celyad Oncology is -3.29
      What is the cash to sales ratio of Celyad Oncology?
      The cash to sales ratio of Celyad Oncology is 268
      What is the reporting currency for Celyad Oncology?
      Celyad Oncology reports financial results in EUR
      What is the latest annual turnover for Celyad Oncology?
      The latest annual turnover of Celyad Oncology is EUR 102k
      What is the latest annual profit for Celyad Oncology?
      The latest annual profit of Celyad Oncology is EUR -8.45M
      What is the registered address of Celyad Oncology?
      The registered address for Celyad Oncology is AXIS BUSINESS PARK, RUE ANDRE DUMONT 9, MONT-SAINT-GUIBERT, WALLOON BRABANT, 1435
      What is the Celyad Oncology website address?
      The website address for Celyad Oncology is www.celyad.com
      Which industry sector does Celyad Oncology operate in?
      Celyad Oncology operates in the PHARMACEUTICAL PREPARATIONS sector

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      DMSBSDiagnostic Medical Systems
      0.0075 €
      (150.00%)
      		1,000
      ALAGOEPango SA
      0.216 €
      (93.55%)
      		13.2M
      MLSMLSmalto
      0.019 €
      (52.00%)
      		33.89k
      MLAAHAmatheon Agri Holding NV
      0.03 €
      (50.00%)
      		3.45k
      CFNCofina SGPS SA
      26.90 €
      (37.95%)
      		4.6k
      SEQUASequana medical NV
      2.45 €
      (-19.93%)
      		890.68k
      FIPPFipp
      0.116 €
      (-17.73%)
      		1,000
      ECTotalEnergies EP Gabon
      168.50 €
      (-16.58%)
      		30.47k
      MLEFAEduformAction
      0.402 €
      (-16.25%)
      		1.1k
      EIFDSTour Eiffel DS
      0.0052 €
      (-13.33%)
      		50.44k
      ATOAtos SE
      0.0025 €
      (-3.85%)
      		1.49B
      BCPBanco Comercial Portugues SA
      0.4589 €
      (-1.25%)
      		96.8M
      ALVERVergnet
      0.002 €
      (0.00%)
      		34.56M
      ALCYBCybergun
      0.0001 €
      (0.00%)
      		31.17M
      ALHPIHopium SA
      0.0049 €
      (4.26%)
      		29.02M

      Discussion

      View Full Feed
      jour_trader jour_trader 2 minutes ago
      Nice job loading up Roths already!

      I'll be disappointed if Nasrat says we'll be skipping the 80's and going to the 90's revenue wise. Unless he's talking per quarter...  style="font-size: 1em"🤣
      ELTP
      otcsource otcsource 2 minutes ago
      CSTI Flashed 0.0007 BID ON WATCH.
      TWOH
      totffe totffe 2 minutes ago
      Still a great category and a stock here with huge potential. Stuff like this happens on the OTC. Holding long
      QNCCF
      glenn1919 glenn1919 3 minutes ago
      ZBAI................................https://stockcharts.com/h-sc/ui?s=ZBAI&p=W&b=5&g=0&id=p86431144783
      ZBAI
      Lone Clone Lone Clone 3 minutes ago
      Critical One Energy: High-Grade, Low-Cost Uranium Recovery at Khan Project

      https://www.globenewswire.com/news-release/2025/01/02/3003435/0/en/Critical-One-High-Grade-Low-Cost-Uranium-Recovery-at-Khan-Project.html

      January 02, 2025 06:50 ET | Source: Critical One Energy
      CRTL MMTLF
      linkvest linkvest 3 minutes ago
      We have an idiot that just took out the 5s to scare folks to sell their 4s... We need to slap that ASK and run this BEAST up top the 7s and watch that dufus scream and cry LMAO....
      ASII
      Budots Budots 3 minutes ago
      $CBDW and Adnexus Biotech Forge Strategic Partnership to Drive Innovation at the Intersection of AI and Biotech
      https://cbdw.ai/1606-corp-cbdw-and-adnexus-biotech-forge-strategic-partnership-to-drive-innovation-at-the-intersection-of-ai-and-biotech/
      CBDW
      Budots Budots 3 minutes ago
      $CBDW and Adnexus Biotech Forge Strategic Partnership to Drive Innovation at the Intersection of AI and Biotech
      https://cbdw.ai/1606-corp-cbdw-and-adnexus-biotech-forge-strategic-partnership-to-drive-innovation-at-the-intersection-of-ai-and-biotech/
      CBDW
      cjstocksup cjstocksup 4 minutes ago
      New York City (5th Avenue) just a few hours after a Jihadist kiIIed 15 in New Orleans:
      https://x.com/EndWokeness/status/1874669301913067957
      lakers17 lakers17 4 minutes ago
      $413, is the low in TSLA? Your charting is worthless TSLA sitting at $375. Never seen anyone this bad at charting. Switch to a coin flip. You'll do better. Your OTC calls via charts remain absurd.

      KEY REVERSAL DAY ALERT! 413.70 low is in! now 421.70
      TSLA
      Steady_T Steady_T 4 minutes ago
      From the Science Direct Website.
      What are corrected proofs?
      Corrected proofs are Articles in Press that contain the author’s corrections. Final citation details (e.g., volume and/or issue number, publication year, and page numbers) still need to be added and the text might change befor
      AVXL
      JusDePomme JusDePomme 4 minutes ago
      Remember affu os 1.2bil But unrestricted shares only 702,477,793 for trading.
      AFFU
      otcsource otcsource 4 minutes ago
      L2 13 2.4 M. 14 7 M powder for PH!?!?
      TWOH
      northam43 northam43 4 minutes ago
      Report #12 SPXS Bear Cycle. The SPXS Bear Cycle ended at the close on Tuesday. Due to the confirmation of the 60-S-2 today during the 1st hour, the 11th SPXS Bear Cycle of this year has ended. The average # of cycles per year is 12.83. This cycle lasted 14 trading days, the average cycle lasts 22.3
      SPXS
      barmarty barmarty 5 minutes ago
      where can you look to see if the paperwork has been filed. or do you just have to wait for it to be published. where at the otc. i don't know
      APRU
      Elroy Jetson Elroy Jetson 5 minutes ago
      I sold all our O and half of our ABBV at the open to fund our next two years of living.

      No more IRA, all in Roths.
      ABBV
      lodas lodas 5 minutes ago
      The usual losers showing up on the message board for 2025 espousing payments to be made to them without documents, nor any verification by the company which is supposed to pay them!!!.....I posted the WMIH Dec 2013 10-K , which AZCowboy says include the language for recovery, yet , no one reads it t
      COOP
      jog49 jog49 6 minutes ago
      I have always thought that Paulson/Bush set up FHFA in 2008 to oversee the orderly demise of Fannie and Freddie, at which time their beloved Goldman-Sachs and such vermin would jump in like hyenas on a fresh kill, leaving nothing but a pile of bones. Over the years, things got tougher for that missi
      FNMA
      linkvest linkvest 6 minutes ago
      Got an empty condo in Ohio but its been snowing... To cold for me. LOL BURRRR
      ASII
      JOoa0ky JOoa0ky 6 minutes ago
      Amazes me how lost Howard is.
      FNMA
      JusDePomme JusDePomme 6 minutes ago
      Asii another one ....2025 start of penny runner!
      AFFU
      glenn1919 glenn1919 7 minutes ago
      frgt.....nrxp.......zbai.........................https://stockcharts.com/h-sc/ui?s=nrxp&p=W&yr=1&mn=3&dy=0&id=p96837884856
      janice shell janice shell 8 minutes ago
      This odd-sounding dish is very popular with Food & Wine reviewers:

      Yellow Curry Rigatoni

      Pickle juice, mustard greens, curry paste, and coconut milk are an unlikely combination that yields a tangy, spicy pasta.

      https://investorshub.advfn.com/uimage/upload

      Your Recent History

      EU
      CYAD
      Celyad Oncology
      BOV
      JPPC11
      Jpp Capital Fundo Invest...
      BIT
      SALZ5S
      SG Issuer Societe Generale
      Delayed Upgrade Clock

      Go Ad-Free

      Subscribe to Ad free and enjoy an ad-free experience

      No Ads

      Try Now

      Keep the Ads